HealthLynked (HLYK) Cash & Equivalents (2016 - 2026)

HealthLynked has disclosed Cash & Equivalents across 11 years of filings, most recently posting $23973.0 for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 7.65% year-over-year to $23973.0; the TTM figure through Mar 2026 stood at $23973.0 (up 7.65% YoY), while the FY2025 annual figure was $37136.0, down 51.29% from the prior year.
• Cash & Equivalents eased to $23973.0 in Q1 2026, from $37136.0 in the prior quarter.
• Over the last five years, Cash & Equivalents for HLYK reached as high as $4.1 million in Q1 2023 and fell as low as $10911.0 in Q3 2025.
• The 5-year median for Cash & Equivalents is $61891.0 (2022), against an average of $546478.1.
• Annual changes were most pronounced in 2023 — Cash & Equivalents soared 745.31% — and 2024, when it tumbled 99.42%.
• A 5-year view of Cash & Equivalents shows it stood at $61891.0 in 2022, then jumped by 299.45% to $247222.0 in 2023, then slumped by 69.16% to $76241.0 in 2024, then sank by 51.29% to $37136.0 in 2025, then plunged by 35.45% to $23973.0 in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $23973.0, $37136.0, and $10911.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.